tirzepatide compound lawsuit update The @strivepharmacy response to the Eli Lilly lawsuits over #tirzepatide March 10, 2025: Patients transitioning

2026 WADA Monitoring Program (Substances NOT prohibited but monitored for potential misuse) Under Article 4.5 of the Code, WADA monitors certain substances to detect patterns of misuse

Theres something called diabetes insipidus, which isnt really connected to what most people think of as diabetes nowadays at all

Overdosing can lead to serious complications like kidney or liver issues

Large-scale randomised controlled trials and post-marketing surveillance data have not identified ED as a common or characteristic adverse effect of these medications

Common side effects include hot flushes, mood changes and osteoporosis

The key differences: Saxenda (liraglutide) was the first GLP-1 medication approved specifically for weight loss and requires daily injections